Table 1 Cumulative incidence (%) of other malignancies and CVDs and mortality (%) by cause of death in younger and older age cohorts.

From: Survival of patients with classical Hodgkin lymphoma in Finland: a national population-based analysis

Younger cohort

Follow-up time (years)

Older cohort

Follow-up time (years)

1

5

10

15

20

1

5

10

15

20

Cum. incidence

Solid malignancy

cHL

2.6

4.9

7.7

9.7

13.8

Cum. incidence

Solid malignancy

cHL

3.6

8.7

14.0

17.2

17.2

Control

0.1

0.4

1.0

1.9

3.6

Control

2.0

9.8

16.7

20.4

24.5

Cum. incidence Myeloid malignancy

cHL

0.2

0.5

0.7

1.0

1.0

Cum. incidence Myeloid malignancy

cHL

0.2

1.0

1.2

1.5

1.5

Control

0.0

0.1

0.2

0.2

0.2

Control

0.1

0.7

0.9

0.9

1.9

Cum. incidence

CVD

cHL

0.9

3.5

7.0

12.1

17.4

Cum. incidence

CVD

cHL

5.3

13.7

20.5

28.2

33.2

Control

0.3

1.6

3.9

5.9

9.6

Control

4.8

18.2

32.2

40.9

48.1

OS rate (%)

cHL

99.3

96.6

94.6

92.8

90.9

OS rate (%)

cHL

72.1

55.1

41.8

31.4

22.7

Control

100

99.7

99.2

98.4

97.3

Control

97.1

85.5

68.5

58.7

40.1

Cum. mortality

cHL

cHL

0.5

2.6

3.7

4.2

4.2

Cum. mortality

cHL

cHL

21.7

30.9

33.8

34.7

34.7

Control

0.0

0.0

0.0

0.0

0.0

Control

0.0

0.0

0.0

0.0

0.0

Cum. mortality

Other lymphomaa

cHL

0.0

0.1

0.1

0.1

0.1

Cum. mortality

Other lymphomaa

cHL

0.7

2.2

4.2

4.2

4.2

Control

0.0

0.0

0.0

0.0

0.0

Control

0.0

0.0

0.0

0.0

0.0

Cum. mortality

Solid malignancy

cHL

0.0

0.0

0.1

0.6

1.6

Cum. mortality

Solid malignancy

cHL

0.2

1.6

4.3

6.4

7.0

Control

0.0

0.0

0.2

0.4

1.1

Control

0.6

2.9

6.5

8.2

11.4

Cum. mortality Myeloid malignancy

cHL

0.0

0.0

0.1

0.3

0.3

Cum. mortality Myeloid malignancy

cHL

0.0

0.1

0.4

0.7

0.7

Control

0.0

0.0

0.0

0.0

0.0

Control

0.0

0.3

0.5

0.5

0.5

Cum. mortality

CVD

cHL

0.0

0.2

0.4

0.5

0.9

Cum. mortality

CVD

cHL

2.2

4.5

6.6

9.5

9.5

Control

0.0

0.0

0.1

0.1

0.1

Control

1.4

4.9

9.3

12.8

17.0

Cum. mortality Otherb

cHL

0.2

0.4

1.0

1.3

1.9

Cum. mortality Otherb

cHL

3.0

5.6

8.9

13.1

21.2

Control

0.0

0.3

0.5

1.1

1.6

Control

0.8

6.4

15.3

19.8

31.0

  1. Cum cumulative, OS overall survival, CVD cardiovascular disease, cHL classical Hodgkin lymphoma.
  2. Other lymphoma: ICD-10: C82-C85.
  3. Solid malignancy: ICD-10: C00-80.
  4. Other myeloid malignancy: ICD-10: C92, D46, D47.
  5. CVD: ICD-10: I10-25, I34-37, I42-43, I46, I50.
  6. aFor controls, any lymphoma diagnosis (C81-85) was an exclusion criteria.
  7. bOther: Any other cause of death.
Back to article page